Doublecortin-like kinase 1 (DCLK1), a biomarker of colorectal CSCs, induces the expression of CXCL1 and CXCL2 through the ERK pathway, facilitating the recruitment of MDSCs into an immunosuppressive TME and promoting tumor growth (22). This evidence concerns the gene CXCL2 and neoplasm.